|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Expenses | |||
| General and administrative | |||
| Research and development | |||
| Total expenses | |||
| Other income/(expenses) | |||
| Interest income | |||
| Interest expense | |||
| Gain (loss) on sale of equipment | |||
| Foreign exchange gain (loss) | |||
| Convertible debt costs | |||
| Change in fair value of financial instruments | |||
| Total other income/(loss) | |||
| Loss before tax expense | |||
| Tax expense | |||
| Net loss for the year | |||
| Foreign currency translation adjustment | |||
| Comprehensive loss for the year | |||
| Loss per share – basic | |||
| Loss per share – diluted | |||
| Weighted average shares outstanding – basic | |||
| Weighted average shares outstanding – diluted | |||
| Loss attributable to: | |||
| Owners of the Company | |||
| Non-controlling interest |
Loading...
